Literature DB >> 28855175

Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study.

John Svensson1,2, Marie Holmqvist2,3, Ingrid E Lundberg1,3, Elizabeth V Arkema2.   

Abstract

OBJECTIVES: To investigate the association between infection or respiratory tract disease and future risk of developing idiopathic inflammatory myopathy (IIM).
METHODS: A case-control study was performed using Swedish nationwide registers. Adults with newly diagnosed IIM were identified (2002-2011) from the National Patient Register (NPR) and the Swedish Rheumatology Register (n=957). Controls were matched by age, sex and place of residence (n=9476). Outpatient visits and hospitalisations preceding IIM diagnosis indicating infection or respiratory disease were identified from NPR. Conditional logistic regression models were used to calculate OR and 95% CI. Sensitivity analyses were performed by varying the exposure definition, adjusting for previous healthcare consumption and excluding individuals with connective tissue disease, IIM lung phenotype or IIM-associated cancer.
RESULTS: Preceding infections were more common in IIM cases compared with controls (13% vs 9%) and were associated with an increased risk of IIM (OR 1.5, 95% CI 1.2 to 1.9). Gastrointestinal and respiratory tract infections were associated with an increased risk of IIM while cutaneous infections were not.Preceding respiratory tract disease was present in 10% of IIM cases and 4% of controls (OR 2.3, 95% CI 1.8 to 3.0). Both upper and lower respiratory tract diseases were associated with an increased risk of IIM.Variations in exposure and outcome definitions did not greatly affect the results.
CONCLUSIONS: Infections and respiratory tract diseases are associated with an increased risk of IIM which suggests that the triggering of the immune system may take place outside the skeletal muscle. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  dermatomyositis; epidemiology; infections; polymyositis

Mesh:

Year:  2017        PMID: 28855175     DOI: 10.1136/annrheumdis-2017-211174

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

Review 1.  Triggers of inflammatory myopathy: insights into pathogenesis.

Authors:  Brittany L Adler; Lisa Christopher-Stine
Journal:  Discov Med       Date:  2018-02       Impact factor: 2.970

Review 2.  Risk factors and disease mechanisms in myositis.

Authors:  Frederick W Miller; Janine A Lamb; Jens Schmidt; Kanneboyina Nagaraju
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

Review 3.  Idiopathic inflammatory myopathies.

Authors:  Ingrid E Lundberg; Manabu Fujimoto; Jiri Vencovsky; Rohit Aggarwal; Marie Holmqvist; Lisa Christopher-Stine; Andrew L Mammen; Frederick W Miller
Journal:  Nat Rev Dis Primers       Date:  2021-12-02       Impact factor: 52.329

4.  Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome.

Authors:  Yinli Zhang; Yongpeng Ge; Hanbo Yang; He Chen; Xiaolan Tian; Zhenguo Huang; Shengyun Liu; Xin Lu; Guochun Wang
Journal:  Clin Rheumatol       Date:  2020-03-06       Impact factor: 2.980

Review 5.  Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies.

Authors:  Alexander Oldroyd; Hector Chinoy
Journal:  Curr Opin Rheumatol       Date:  2018-11       Impact factor: 5.006

6.  Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease.

Authors:  Naoshi Nishina; Shinji Sato; Kenichi Masui; Takahisa Gono; Masataka Kuwana
Journal:  RMD Open       Date:  2020-06

Review 7.  Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment.

Authors:  Baptiste Hervier; Yurdagül Uzunhan
Journal:  Front Med (Lausanne)       Date:  2020-01-17

Review 8.  Natural killer cells in inflammatory autoimmune diseases.

Authors:  Yuyan Yang; Jessica Day; Fernando Souza-Fonseca Guimaraes; Ian P Wicks; Cynthia Louis
Journal:  Clin Transl Immunology       Date:  2021-02-01

9.  Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis.

Authors:  Spyridon Megremis; Thomas D J Walker; Xiaotong He; James O'Sullivan; William E R Ollier; Hector Chinoy; Neil Pendleton; Antony Payton; Lynne Hampson; Ian Hampson; Janine A Lamb
Journal:  Commun Biol       Date:  2021-03-26

10.  ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis.

Authors:  Takashi Matsuo; Tsuneo Sasai; Ran Nakashima; Yoshihiro Kuwabara; Eri Toda Kato; Isao Murakami; Hideo Onizawa; Shuji Akizuki; Kosaku Murakami; Motomu Hashimoto; Hajime Yoshifuji; Masao Tanaka; Akio Morinobu; Tsuneyo Mimori
Journal:  Front Immunol       Date:  2022-01-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.